Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rab3 GTPase-activating protein catalytic subunit 1 (RAB3GAP1) is the catalytic component of the Rab3GAP complex, a heterodimer composed of RAB3GAP1 (130 kDa) and RAB3GAP2 (150 kDa). This complex regulates Rab3 subfamily GTPases by stimulating the conversion of Rab3-GTP to Rab3-GDP, thereby controlling regulated exocytosis of neurotransmitters and hormones. Rab3GAP1 also displays guanine nucleotide exchange factor (GEF) activity for Rab18, promoting its recruitment and activation at membrane compartments such as the ER and Golgi. Functions of RAB3GAP1 include organizing vesicle trafficking, cellular lipid storage and release, autophagy, and neurodevelopment. Pathogenic mutations in RAB3GAP1 disrupt normal protein function and are the primary cause of Warburg micro syndrome, a rare autosomal recessive disorder with postnatal growth retardation, microcephaly, congenital cataracts, optic atrophy, spastic paraplegia, and hypogonadism. Martsolf syndrome is a milder form with reduced protein function. No drugs directly targeting RAB3GAP1 are reported, and no established biomarkers or safety concerns exist beyond its genetic deficiency syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rab3 GTPase-activating protein catalytic subunit 1 (RAB3GAP1).